CLDN1-overexpressing SW620 cells and a xenograft tumor model were cotreated with the anti-CD81 monoclonal antibody (mAb) 5A6 to investigate the role of the CLDN1/CD81 axis in CRC tumor growth. This evidence concerns the gene CD81 and neoplasm.